Home

Jeffrey Ferrell

CIK 1394967 · last filed 2024-08-14

Jeffrey Ferrell is a corporate insider who has filed 12 SEC Form 4 insider transactions across 2 companies since 2013. The most recent filing, for BIOR, was dated Aug 14, 2024. 14 SEC filings were submitted jointly with Athyrium Funds GP Holdings LLC.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

2

Total Filings

12

Lifetime Open-Market Net

$0

Filer Profile

Reported Address
ATHYRIUM CAPITAL MANAGEMENT, LP
505 FIFTH AVENUE, FL 18
NEW YORK, NY 10017
Related Filers
Athyrium Funds GP Holdings LLC — 14 joint filings, latest 2024-12-16
Athyrium Opportunities III Acquisition LP — 11 joint filings, latest 2024-12-16
Athyrium Opportunities 2020 LP — 8 joint filings, latest 2024-12-16
Athyrium Opportunities Associates III GP LLC — 8 joint filings, latest 2024-12-16
Athyrium Opportunities III Acquisition 2 LP — 8 joint filings, latest 2024-12-16
Athyrium Capital Holdings, LLC — 5 joint filings, latest 2021-06-14
Athyrium Capital Management, LP — 5 joint filings, latest 2021-06-14
NB Alternatives Advisers LLC — 5 joint filings, latest 2021-06-14
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
BIORA THERAPEUTICS, INC. (BIOR) Delisted Director 169,448 $0.22 $37.3K $0 2 2024-08-14
Apollo Endosurgery, Inc. (LPTN) Delisted Director 2,270 — — $0 6 2016-03-16

Recent Filings

12 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2024-08-14 BIORA THERAPEUTICS, INC. (BIOR) Delisted Mixed — $0 EDGAR
2022-11-14 BIORA THERAPEUTICS, INC. (BIOR) Delisted Mixed +112,556,250 $0 EDGAR
2016-03-16 Apollo Endosurgery, Inc. (LPTN) Delisted Exer (M) +3,485 $0 EDGAR
2016-02-18 Apollo Endosurgery, Inc. (LPTN) Delisted Grant (A) — $0 EDGAR
2015-04-23 Apollo Endosurgery, Inc. (LPTN) Delisted Exer (M) +5,715 $0 EDGAR
2015-02-12 Apollo Endosurgery, Inc. (LPTN) Delisted Grant (A) — $0 EDGAR
2014-02-12 Apollo Endosurgery, Inc. (LPTN) Delisted Mixed +3,286 $0 EDGAR
2013-01-31 Apollo Endosurgery, Inc. (LPTN) Delisted Grant (A) — $0 EDGAR
2012-03-27 — Grant (A) — $0
2011-03-11 — Grant (A) — $0
Showing 1–10 of 12
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.